|  Help  |  About  |  Contact Us

Search our database by keyword

Examples

  • Search this entire website. Enter identifiers, names or keywords for genes, diseases, strains, ontology terms, etc. (e.g. Pax6, Parkinson, ataxia)
  • Use OR to search for either of two terms (e.g. OR mus) or quotation marks to search for phrases (e.g. "dna binding").
  • Boolean search syntax is supported: e.g. Balb* for partial matches or mus AND NOT embryo to exclude a term

Search results 101 to 200 out of 732 for Nr1h4

0.037s

Categories

Hits by Pathway

Hits by Strain

Hits by Category

Type Details Score
Publication
First Author: Peng X
Year: 2014
Journal: Biochem Biophys Res Commun
Title: Activation of farnesoid X receptor induces RECK expression in mouse liver.
Volume: 443
Issue: 1
Pages: 211-6
Publication
First Author: Zhu Y
Year: 2013
Journal: Toxicol Appl Pharmacol
Title: Modulation of farnesoid X receptor results in post-translational modification of poly (ADP-ribose) polymerase 1 in the liver.
Volume: 266
Issue: 2
Pages: 260-6
Publication
First Author: Zhang Y
Year: 2004
Journal: Genes Dev
Title: Peroxisome proliferator-activated receptor-gamma coactivator 1alpha (PGC-1alpha) regulates triglyceride metabolism by activation of the nuclear receptor FXR.
Volume: 18
Issue: 2
Pages: 157-69
Publication
First Author: Renga B
Year: 2013
Journal: PLoS One
Title: The bile acid sensor FXR is required for immune-regulatory activities of TLR-9 in intestinal inflammation.
Volume: 8
Issue: 1
Pages: e54472
Publication
First Author: Singh AB
Year: 2018
Journal: Arterioscler Thromb Vasc Biol
Title: Farnesoid X Receptor Activation by Obeticholic Acid Elevates Liver Low-Density Lipoprotein Receptor Expression by mRNA Stabilization and Reduces Plasma Low-Density Lipoprotein Cholesterol in Mice.
Volume: 38
Issue: 10
Pages: 2448-2459
Publication
First Author: Williams JA
Year: 2012
Journal: PLoS One
Title: Tissue specific induction of p62/Sqstm1 by farnesoid X receptor.
Volume: 7
Issue: 8
Pages: e43961
Publication
First Author: Hao H
Year: 2017
Journal: Cell Metab
Title: Farnesoid X Receptor Regulation of the NLRP3 Inflammasome Underlies Cholestasis-Associated Sepsis.
Volume: 25
Issue: 4
Pages: 856-867.e5
Publication
First Author: Inoue J
Year: 2008
Journal: Biochem Biophys Res Commun
Title: PPARalpha gene expression is up-regulated by LXR and PXR activators in the small intestine.
Volume: 371
Issue: 4
Pages: 675-8
Publication
First Author: Li G
Year: 2013
Journal: Am J Physiol Gastrointest Liver Physiol
Title: Mechanisms of STAT3 activation in the liver of FXR knockout mice.
Volume: 305
Issue: 11
Pages: G829-37
Publication
First Author: Renga B
Year: 2011
Journal: Biochim Biophys Acta
Title: Farnesoid X receptor suppresses constitutive androstane receptor activity at the multidrug resistance protein-4 promoter.
Volume: 1809
Issue: 3
Pages: 157-65
Publication
First Author: Boyer JL
Year: 2006
Journal: Am J Physiol Gastrointest Liver Physiol
Title: Upregulation of a basolateral FXR-dependent bile acid efflux transporter OSTalpha-OSTbeta in cholestasis in humans and rodents.
Volume: 290
Issue: 6
Pages: G1124-30
Publication
First Author: Lee H
Year: 2006
Journal: J Lipid Res
Title: FXR regulates organic solute transporters alpha and beta in the adrenal gland, kidney, and intestine.
Volume: 47
Issue: 1
Pages: 201-14
Publication
First Author: Renga B
Year: 2012
Journal: FASEB J
Title: Glucocorticoid receptor mediates the gluconeogenic activity of the farnesoid X receptor in the fasting condition.
Volume: 26
Issue: 7
Pages: 3021-31
Publication
First Author: Seok S
Year: 2014
Journal: Nature
Title: Transcriptional regulation of autophagy by an FXR-CREB axis.
Volume: 516
Issue: 7529
Pages: 108-11
Publication
First Author: Zollner G
Year: 2006
Journal: Am J Physiol Gastrointest Liver Physiol
Title: Coordinated induction of bile acid detoxification and alternative elimination in mice: role of FXR-regulated organic solute transporter-alpha/beta in the adaptive response to bile acids.
Volume: 290
Issue: 5
Pages: G923-32
Publication
First Author: Fu T
Year: 2022
Journal: Proc Natl Acad Sci U S A
Title: FXR mediates ILC-intrinsic responses to intestinal inflammation.
Volume: 119
Issue: 51
Pages: e2213041119
Publication
First Author: Korstanje R
Year: 2004
Journal: Arterioscler Thromb Vasc Biol
Title: Quantitative trait locus mapping of genes that regulate phospholipid transfer activity in SM/J and NZB/BlNJ inbred mice.
Volume: 24
Issue: 1
Pages: 155-60
Publication
First Author: Han CY
Year: 2018
Journal: Cell Rep
Title: FXR Inhibits Endoplasmic Reticulum Stress-Induced NLRP3 Inflammasome in Hepatocytes and Ameliorates Liver Injury.
Volume: 24
Issue: 11
Pages: 2985-2999
Publication
First Author: Ma K
Year: 2006
Journal: J Clin Invest
Title: Farnesoid X receptor is essential for normal glucose homeostasis.
Volume: 116
Issue: 4
Pages: 1102-9
Publication
First Author: Inagaki T
Year: 2006
Journal: Proc Natl Acad Sci U S A
Title: Regulation of antibacterial defense in the small intestine by the nuclear bile acid receptor.
Volume: 103
Issue: 10
Pages: 3920-5
Publication
First Author: Modica S
Year: 2012
Journal: Gastroenterology
Title: Selective activation of nuclear bile acid receptor FXR in the intestine protects mice against cholestasis.
Volume: 142
Issue: 2
Pages: 355-65.e1-4
Publication
First Author: de Aguiar Vallim TQ
Year: 2015
Journal: Cell Metab
Title: MAFG is a transcriptional repressor of bile acid synthesis and metabolism.
Volume: 21
Issue: 2
Pages: 298-310
Publication
First Author: Pathak P
Year: 2017
Journal: J Biol Chem
Title: Farnesoid X receptor induces Takeda G-protein receptor 5 cross-talk to regulate bile acid synthesis and hepatic metabolism.
Volume: 292
Issue: 26
Pages: 11055-11069
Publication
First Author: Degirolamo C
Year: 2014
Journal: Cell Rep
Title: Microbiota modification with probiotics induces hepatic bile acid synthesis via downregulation of the Fxr-Fgf15 axis in mice.
Volume: 7
Issue: 1
Pages: 12-8
Publication
First Author: Schupp AK
Year: 2016
Journal: J Virol
Title: Bile Acids Act as Soluble Host Restriction Factors Limiting Cytomegalovirus Replication in Hepatocytes.
Volume: 90
Issue: 15
Pages: 6686-98
Publication  
First Author: Dong X
Year: 2024
Journal: JCI Insight
Title: Farnesoid X receptor mediates macrophage-intrinsic responses to suppress colitis-induced colon cancer progression.
Volume: 9
Issue: 2
Publication
First Author: Cariello M
Year: 2017
Journal: Sci Rep
Title: Long-term Administration of Nuclear Bile Acid Receptor FXR Agonist Prevents Spontaneous Hepatocarcinogenesis in Abcb4-/- Mice.
Volume: 7
Issue: 1
Pages: 11203
Publication
First Author: de Aguiar Vallim TQ
Year: 2013
Journal: Circ Res
Title: MicroRNA-144 regulates hepatic ATP binding cassette transporter A1 and plasma high-density lipoprotein after activation of the nuclear receptor farnesoid X receptor.
Volume: 112
Issue: 12
Pages: 1602-12
Publication
First Author: Akinrotimi O
Year: 2017
Journal: Hepatology
Title: Small heterodimer partner deletion prevents hepatic steatosis and when combined with farnesoid X receptor loss protects against type 2 diabetes in mice.
Volume: 66
Issue: 6
Pages: 1854-1865
Publication
First Author: Liu B
Year: 2010
Journal: J Lipid Res
Title: Cyclodextrin overcomes the transport defect in nearly every organ of NPC1 mice leading to excretion of sequestered cholesterol as bile acid.
Volume: 51
Issue: 5
Pages: 933-44
Publication
First Author: Miyata M
Year: 2017
Journal: J Toxicol Sci
Title: Fish oil feeding reverses hepatomegaly and disrupted hepatic function due to the lack of FXR signaling.
Volume: 42
Issue: 6
Pages: 671-681
Publication
First Author: Claudel T
Year: 2003
Journal: Gastroenterology
Title: Farnesoid X receptor agonists suppress hepatic apolipoprotein CIII expression.
Volume: 125
Issue: 2
Pages: 544-55
Publication
First Author: Cariou B
Year: 2006
Journal: J Biol Chem
Title: The farnesoid X receptor modulates adiposity and peripheral insulin sensitivity in mice.
Volume: 281
Issue: 16
Pages: 11039-49
Publication
First Author: Zhang Y
Year: 2006
Journal: Proc Natl Acad Sci U S A
Title: Activation of the nuclear receptor FXR improves hyperglycemia and hyperlipidemia in diabetic mice.
Volume: 103
Issue: 4
Pages: 1006-11
Publication
First Author: Modica S
Year: 2008
Journal: Cancer Res
Title: Nuclear bile acid receptor FXR protects against intestinal tumorigenesis.
Volume: 68
Issue: 23
Pages: 9589-94
Publication
First Author: Popescu IR
Year: 2010
Journal: FEBS Lett
Title: The nuclear receptor FXR is expressed in pancreatic beta-cells and protects human islets from lipotoxicity.
Volume: 584
Issue: 13
Pages: 2845-51
Publication
First Author: Jain U
Year: 2018
Journal: Cell Host Microbe
Title: Temporal Regulation of the Bacterial Metabolite Deoxycholate during Colonic Repair Is Critical for Crypt Regeneration.
Volume: 24
Issue: 3
Pages: 353-363.e5
Publication
First Author: Bijsmans IT
Year: 2017
Journal: Biochim Biophys Acta
Title: Characterization of stem cell-derived liver and intestinal organoids as a model system to study nuclear receptor biology.
Volume: 1863
Issue: 3
Pages: 687-700
Publication
First Author: Prade E
Year: 2012
Journal: Mol Endocrinol
Title: Bile acids down-regulate caveolin-1 in esophageal epithelial cells through sterol responsive element-binding protein.
Volume: 26
Issue: 5
Pages: 819-32
Publication
First Author: Zaufel A
Year: 2021
Journal: Biochim Biophys Acta Mol Basis Dis
Title: Secondary (iso)BAs cooperate with endogenous ligands to activate FXR under physiological and pathological conditions.
Volume: 1867
Issue: 8
Pages: 166153
Publication
First Author: Zhang Y
Year: 2006
Journal: Arterioscler Thromb Vasc Biol
Title: FXR deficiency causes reduced atherosclerosis in Ldlr-/- mice.
Volume: 26
Issue: 10
Pages: 2316-21
Publication
First Author: Abdelkarim M
Year: 2010
Journal: J Biol Chem
Title: The farnesoid X receptor regulates adipocyte differentiation and function by promoting peroxisome proliferator-activated receptor-gamma and interfering with the Wnt/beta-catenin pathways.
Volume: 285
Issue: 47
Pages: 36759-67
Publication
First Author: Anakk S
Year: 2011
Journal: J Clin Invest
Title: Combined deletion of Fxr and Shp in mice induces Cyp17a1 and results in juvenile onset cholestasis.
Volume: 121
Issue: 1
Pages: 86-95
Publication
First Author: Stedman C
Year: 2006
Journal: Proc Natl Acad Sci U S A
Title: Benefit of farnesoid X receptor inhibition in obstructive cholestasis.
Volume: 103
Issue: 30
Pages: 11323-8
Publication
First Author: Mencarelli A
Year: 2009
Journal: Am J Physiol Heart Circ Physiol
Title: Antiatherosclerotic effect of farnesoid X receptor.
Volume: 296
Issue: 2
Pages: H272-81
Publication
First Author: Guo GL
Year: 2006
Journal: Biochim Biophys Acta
Title: Effects of FXR in foam-cell formation and atherosclerosis development.
Volume: 1761
Issue: 12
Pages: 1401-9
Publication
First Author: Hanniman EA
Year: 2005
Journal: J Lipid Res
Title: Loss of functional farnesoid X receptor increases atherosclerotic lesions in apolipoprotein E-deficient mice.
Volume: 46
Issue: 12
Pages: 2595-604
Publication
First Author: Qiu Y
Year: 2020
Journal: Diabetologia
Title: The glucose-lowering effects of α-glucosidase inhibitor require a bile acid signal in mice.
Volume: 63
Issue: 5
Pages: 1002-1016
Publication
First Author: Xiang M
Year: 2023
Journal: iScience
Title: Aquaporin-8 ameliorates hepatic steatosis through farnesoid X receptor in obese mice.
Volume: 26
Issue: 4
Pages: 106561
Publication
First Author: DePaoli AM
Year: 2019
Journal: Diabetes
Title: FGF19 Analog as a Surgical Factor Mimetic That Contributes to Metabolic Effects Beyond Glucose Homeostasis.
Volume: 68
Issue: 6
Pages: 1315-1328
Publication
First Author: Sinal CJ
Year: 2000
Journal: Cell
Title: Targeted disruption of the nuclear receptor FXR/BAR impairs bile acid and lipid homeostasis.
Volume: 102
Issue: 6
Pages: 731-44
Publication
First Author: Chennamsetty I
Year: 2011
Journal: J Clin Invest
Title: Farnesoid X receptor represses hepatic human APOA gene expression.
Volume: 121
Issue: 9
Pages: 3724-34
Publication
First Author: Saeed A
Year: 2019
Journal: Sci Rep
Title: Farnesoid X receptor and bile acids regulate vitamin A storage.
Volume: 9
Issue: 1
Pages: 19493
Publication  
First Author: Kim EY
Year: 2022
Journal: Int J Mol Sci
Title: Transcriptional Control of Trpm6 by the Nuclear Receptor FXR.
Volume: 23
Issue: 4
Publication
First Author: Alam G
Year: 2020
Journal: Pflugers Arch
Title: Activation of farnesoid X receptor (FXR) induces crystallin zeta expression in mouse medullary collecting duct cells.
Volume: 472
Issue: 11
Pages: 1631-1641
Publication
First Author: Xu S
Year: 2018
Journal: Proc Natl Acad Sci U S A
Title: Farnesoid X receptor is essential for the survival of renal medullary collecting duct cells under hypertonic stress.
Volume: 115
Issue: 21
Pages: 5600-5605
Publication
First Author: Chow EC
Year: 2014
Journal: Gastroenterology
Title: Vitamin D receptor activation down-regulates the small heterodimer partner and increases CYP7A1 to lower cholesterol.
Volume: 146
Issue: 4
Pages: 1048-59
Publication
First Author: Wang YD
Year: 2015
Journal: Mol Endocrinol
Title: Farnesoid X receptor antagonizes JNK signaling pathway in liver carcinogenesis by activating SOD3.
Volume: 29
Issue: 2
Pages: 322-31
Publication
First Author: Allen K
Year: 2011
Journal: Am J Pathol
Title: Bile acids induce inflammatory genes in hepatocytes: a novel mechanism of inflammation during obstructive cholestasis.
Volume: 178
Issue: 1
Pages: 175-86
Publication
First Author: Zhang Y
Year: 2010
Journal: J Biol Chem
Title: Identification of novel pathways that control farnesoid X receptor-mediated hypocholesterolemia.
Volume: 285
Issue: 5
Pages: 3035-43
Publication
First Author: Iakova P
Year: 2011
Journal: Semin Cancer Biol
Title: Intracellular signaling and hepatocellular carcinoma.
Volume: 21
Issue: 1
Pages: 28-34
Publication
First Author: Cui YJ
Year: 2009
Journal: Toxicol Sci
Title: Compensatory induction of liver efflux transporters in response to ANIT-induced liver injury is impaired in FXR-null mice.
Volume: 110
Issue: 1
Pages: 47-60
Publication
First Author: Jiang C
Year: 2015
Journal: J Clin Invest
Title: Intestinal farnesoid X receptor signaling promotes nonalcoholic fatty liver disease.
Volume: 125
Issue: 1
Pages: 386-402
Publication
First Author: Kim I
Year: 2007
Journal: J Lipid Res
Title: Differential regulation of bile acid homeostasis by the farnesoid X receptor in liver and intestine.
Volume: 48
Issue: 12
Pages: 2664-72
Publication
First Author: Miyazaki-Anzai S
Year: 2018
Journal: J Lipid Res
Title: Simultaneous inhibition of FXR and TGR5 exacerbates atherosclerotic formation.
Volume: 59
Issue: 9
Pages: 1709-1713
Publication
First Author: Tarling EJ
Year: 2017
Journal: J Clin Invest
Title: RNA-binding protein ZFP36L1 maintains posttranscriptional regulation of bile acid metabolism.
Volume: 127
Issue: 10
Pages: 3741-3754
Publication
First Author: Ratliff EP
Year: 2006
Journal: J Lipid Res
Title: Transgenic expression of CYP7A1 in LDL receptor-deficient mice blocks diet-induced hypercholesterolemia.
Volume: 47
Issue: 7
Pages: 1513-20
Publication
First Author: Prawitt J
Year: 2011
Journal: Diabetes
Title: Farnesoid X receptor deficiency improves glucose homeostasis in mouse models of obesity.
Volume: 60
Issue: 7
Pages: 1861-71
Publication
First Author: Guo GL
Year: 2003
Journal: J Biol Chem
Title: Complementary roles of farnesoid X receptor, pregnane X receptor, and constitutive androstane receptor in protection against bile acid toxicity.
Volume: 278
Issue: 46
Pages: 45062-71
Publication
First Author: Volle DH
Year: 2007
Journal: Genes Dev
Title: The small heterodimer partner is a gonadal gatekeeper of sexual maturation in male mice.
Volume: 21
Issue: 3
Pages: 303-15
Publication
First Author: Huang W
Year: 2006
Journal: Science
Title: Nuclear receptor-dependent bile acid signaling is required for normal liver regeneration.
Volume: 312
Issue: 5771
Pages: 233-6
Publication
First Author: Kim KH
Year: 2018
Journal: Endocrinology
Title: Xenobiotic Nuclear Receptor Signaling Determines Molecular Pathogenesis of Progressive Familial Intrahepatic Cholestasis.
Volume: 159
Issue: 6
Pages: 2435-2446
Publication
First Author: Jiang Y
Year: 2013
Journal: Hepatology
Title: Farnesoid X receptor inhibits gankyrin in mouse livers and prevents development of liver cancer.
Volume: 57
Issue: 3
Pages: 1098-106
Publication
First Author: Lan T
Year: 2012
Journal: J Hepatol
Title: Mouse organic solute transporter alpha deficiency alters FGF15 expression and bile acid metabolism.
Volume: 57
Issue: 2
Pages: 359-65
Publication
First Author: Zhang Y
Year: 2012
Journal: Mol Endocrinol
Title: Loss of FXR protects against diet-induced obesity and accelerates liver carcinogenesis in ob/ob mice.
Volume: 26
Issue: 2
Pages: 272-80
Publication
First Author: Gutierrez A
Year: 2006
Journal: Arterioscler Thromb Vasc Biol
Title: Bile acids decrease hepatic paraoxonase 1 expression and plasma high-density lipoprotein levels via FXR-mediated signaling of FGFR4.
Volume: 26
Issue: 2
Pages: 301-6
Publication
First Author: Arab JP
Year: 2017
Journal: Hepatology
Title: Bile acids and nonalcoholic fatty liver disease: Molecular insights and therapeutic perspectives.
Volume: 65
Issue: 1
Pages: 350-362
Publication
First Author: Zhang L
Year: 2009
Journal: Mol Endocrinol
Title: Significance and mechanism of CYP7a1 gene regulation during the acute phase of liver regeneration.
Volume: 23
Issue: 2
Pages: 137-45
Publication
First Author: Seyer P
Year: 2013
Journal: J Clin Invest
Title: Hepatic glucose sensing is required to preserve β cell glucose competence.
Volume: 123
Issue: 4
Pages: 1662-76
Publication
First Author: Gadaleta RM
Year: 2018
Journal: Sci Rep
Title: Suppression of Hepatic Bile Acid Synthesis by a non-tumorigenic FGF19 analogue Protects Mice from Fibrosis and Hepatocarcinogenesis.
Volume: 8
Issue: 1
Pages: 17210
Publication
First Author: Sekiya S
Year: 2011
Journal: Proc Natl Acad Sci U S A
Title: Glycogen synthase kinase 3 β-dependent Snail degradation directs hepatocyte proliferation in normal liver regeneration.
Volume: 108
Issue: 27
Pages: 11175-80
Publication
First Author: Li T
Year: 2012
Journal: J Biol Chem
Title: Glucose and insulin induction of bile acid synthesis: mechanisms and implication in diabetes and obesity.
Volume: 287
Issue: 3
Pages: 1861-73
Publication
First Author: Liu S
Year: 2021
Journal: iScience
Title: Metabolic nuclear receptors coordinate energy metabolism to regulate Sox9+ hepatocyte fate.
Volume: 24
Issue: 9
Pages: 103003
Publication
First Author: Byun S
Year: 2017
Journal: EMBO J
Title: A postprandial FGF19-SHP-LSD1 regulatory axis mediates epigenetic repression of hepatic autophagy.
Volume: 36
Issue: 12
Pages: 1755-1769
Publication
First Author: Kong B
Year: 2012
Journal: Hepatology
Title: Mechanism of tissue-specific farnesoid X receptor in suppressing the expression of genes in bile-acid synthesis in mice.
Volume: 56
Issue: 3
Pages: 1034-43
Publication
First Author: Ma K
Year: 2009
Journal: PLoS One
Title: Circadian dysregulation disrupts bile acid homeostasis.
Volume: 4
Issue: 8
Pages: e6843
Publication
First Author: Yamamoto Y
Year: 2006
Journal: J Biol Chem
Title: Estrogen receptor alpha mediates 17alpha-ethynylestradiol causing hepatotoxicity.
Volume: 281
Issue: 24
Pages: 16625-31
Publication
First Author: Hartman HB
Year: 2009
Journal: J Lipid Res
Title: Loss of small heterodimer partner expression in the liver protects against dyslipidemia.
Volume: 50
Issue: 2
Pages: 193-203
Publication
First Author: Amador-Noguez D
Year: 2007
Journal: Aging Cell
Title: Alterations in xenobiotic metabolism in the long-lived Little mice.
Volume: 6
Issue: 4
Pages: 453-70
Publication
First Author: Yu L
Year: 2005
Journal: J Biol Chem
Title: Expression of ABCG5 and ABCG8 is required for regulation of biliary cholesterol secretion.
Volume: 280
Issue: 10
Pages: 8742-7
Publication
First Author: Cheng X
Year: 2008
Journal: Toxicol Sci
Title: Perfluorocarboxylic acids induce cytochrome P450 enzymes in mouse liver through activation of PPAR-alpha and CAR transcription factors.
Volume: 106
Issue: 1
Pages: 29-36
Publication
First Author: Hang S
Year: 2019
Journal: Nature
Title: Bile acid metabolites control TH17 and Treg cell differentiation.
Volume: 576
Issue: 7785
Pages: 143-148
Publication
First Author: Anakk S
Year: 2013
Journal: Cell Rep
Title: Bile acids activate YAP to promote liver carcinogenesis.
Volume: 5
Issue: 4
Pages: 1060-9
Publication
First Author: Albaugh VL
Year: 2019
Journal: Gastroenterology
Title: Role of Bile Acids and GLP-1 in Mediating the Metabolic Improvements of Bariatric Surgery.
Volume: 156
Issue: 4
Pages: 1041-1051.e4
Publication
First Author: Cheng X
Year: 2008
Journal: Toxicol Sci
Title: Critical role of PPAR-alpha in perfluorooctanoic acid- and perfluorodecanoic acid-induced downregulation of Oatp uptake transporters in mouse livers.
Volume: 106
Issue: 1
Pages: 37-45
Publication
First Author: Liu TC
Year: 2021
Journal: Cell Host Microbe
Title: Western diet induces Paneth cell defects through microbiome alterations and farnesoid X receptor and type I interferon activation.
Volume: 29
Issue: 6
Pages: 988-1001.e6
Publication
First Author: Clifford BL
Year: 2021
Journal: Cell Metab
Title: FXR activation protects against NAFLD via bile-acid-dependent reductions in lipid absorption.
Volume: 33
Issue: 8
Pages: 1671-1684.e4
Publication
First Author: Song X
Year: 2023
Journal: Nature
Title: Gut microbial fatty acid isomerization modulates intraepithelial T cells.
Volume: 619
Issue: 7971
Pages: 837-843
Publication
First Author: O'Leary CE
Year: 2022
Journal: Sci Immunol
Title: Bile acid-sensitive tuft cells regulate biliary neutrophil influx.
Volume: 7
Issue: 69
Pages: eabj1080
Publication
First Author: Xu Y
Year: 2021
Journal: Nat Metab
Title: Hepatocyte ATF3 protects against atherosclerosis by regulating HDL and bile acid metabolism.
Volume: 3
Issue: 1
Pages: 59-74